心力衰竭中的性别差异。
Sex differences in heart failure.
作者信息
Eisenberg Evann, Di Palo Katherine E, Piña Ileana L
机构信息
Department of Cardiology, Cedars-Sinai Medical Center, California, Los Angeles.
Department of Cardiology, Montefiore Medical Center, New York.
出版信息
Clin Cardiol. 2018 Feb;41(2):211-216. doi: 10.1002/clc.22917. Epub 2018 Feb 27.
Abstract
Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.
摘要
在美国，心力衰竭（HF）的患病人数持续增加，约50%的HF患者为女性。对于医疗服务提供者而言，了解性别在识别、诊断和管理中所起的作用至关重要。这篇文献综述的目的是强调女性心力衰竭的患病率，并讨论在流行病学、症状、药理学和治疗方面的性别差异，以及研究女性在临床试验中的代表性。
相似文献
1
Sex differences in heart failure.心力衰竭中的性别差异。
Clin Cardiol. 2018 Feb;41(2):211-216. doi: 10.1002/clc.22917. Epub 2018 Feb 27.
2
Sex differences in heart failure.心力衰竭中的性别差异。
Eur Heart J. 2019 Dec 14;40(47):3859-3868c. doi: 10.1093/eurheartj/ehz835.
3
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.性别差异在心血管病理生理学中的作用：为什么女性在射血分数保留的心力衰竭中更为常见。
Circulation. 2018 Jul 10;138(2):198-205. doi: 10.1161/CIRCULATIONAHA.118.034271.
4
Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem.心房颤动与心力衰竭的流行病学：一个日益严重且重要的问题。
Cardiol Clin. 2019 May;37(2):119-129. doi: 10.1016/j.ccl.2019.01.001. Epub 2019 Feb 22.
5
Heart failure in elderly patients: distinctive features and unresolved issues.老年人心力衰竭：特征和未解决问题。
Eur J Heart Fail. 2013 Jul;15(7):717-23. doi: 10.1093/eurjhf/hft028. Epub 2013 Feb 20.
6
Sex-related differences in heart failure.
Heart Lung. 2003 Jul-Aug;32(4):215-23; quiz 224-5. doi: 10.1016/s0147-9563(03)00025-6.
7
Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.心力衰竭患者与 B 型利钠肽、左心室射血分数和质量以及峰值耗氧量相关的变量的性别差异。
Int J Cardiol. 2011 Jun 16;149(3):364-71. doi: 10.1016/j.ijcard.2010.02.018. Epub 2010 Mar 3.
8
Heart failure with preserved ejection fraction: the dark side of an old disease.射血分数保留的心力衰竭：一种古老疾病的阴暗面。
Arch Cardiol Mex. 2019;89(4):360-368. doi: 10.24875/ACM.19000170.
9
Update of Pediatric Heart Failure.小儿心力衰竭更新。
Pediatr Clin North Am. 2020 Oct;67(5):889-901. doi: 10.1016/j.pcl.2020.06.004. Epub 2020 Aug 11.
10
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.射血分数谱中基于性别的心力衰竭差异：表型、预后和治疗意义。
JACC Heart Fail. 2019 Jun;7(6):505-515. doi: 10.1016/j.jchf.2019.03.011.
引用本文的文献
1
Association of Life's Essential 8 with incidence of heart failure modified by depressive symptoms: a prospective cohort study from UK Biobank.生命必需的八项指标与经抑郁症状修正的心力衰竭发病率的关联：来自英国生物银行的一项前瞻性队列研究。
BMC Med. 2025 Mar 24;23(1):175. doi: 10.1186/s12916-025-04011-3.
2
Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction.髓系脂肪酸代谢激活邻近造血干细胞，促进射血分数保留的心力衰竭。
Circulation. 2025 May 20;151(20):1451-1466. doi: 10.1161/CIRCULATIONAHA.124.070248. Epub 2025 Mar 12.
3
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial.多因素干预对 DKD 患者心血管和死亡风险的性别差异：一项随机临床试验的事后分析。
Cardiovasc Diabetol. 2024 Aug 5;23(1):285. doi: 10.1186/s12933-024-02371-3.
4
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study.癌症诊断前后心力衰竭药物治疗的使用情况：一项纵向研究。
ESC Heart Fail. 2024 Dec;11(6):3911-3923. doi: 10.1002/ehf2.14981. Epub 2024 Jul 23.
5
An Era of Digital Healthcare-A Comprehensive Review of Sensor Technologies and Telehealth Advancements in Chronic Heart Failure Management.数字医疗时代——慢性心力衰竭管理中传感器技术与远程医疗进展的全面综述
Sensors (Basel). 2024 Apr 16;24(8):2546. doi: 10.3390/s24082546.
6
Sex differences in clinical characteristics and long-term outcome in patients with heart failure: data from the KorAHF registry.心力衰竭患者的临床特征和长期预后的性别差异：来自 KorAHF 注册研究的数据。
Korean J Intern Med. 2024 Jan;39(1):95-109. doi: 10.3904/kjim.2023.288. Epub 2023 Dec 14.
7
Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction: A comprehensive literature review.射血分数保留的心力衰竭的性别特异性危险因素、合并症、诊断挑战、最佳治疗方法和预后结果的差异：全面文献综述。
Heart Fail Rev. 2024 Jan;29(1):235-256. doi: 10.1007/s10741-023-10369-4. Epub 2023 Nov 24.
8
Clinical Outcomes in Patients on Hemodialysis with Congestive Heart Failure.充血性心力衰竭的血液透析患者的临床结局
Kidney Dis (Basel). 2023 Mar 3;9(4):306-316. doi: 10.1159/000529802. eCollection 2023 Aug.
9
Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health.代谢与心血管健康药物依从性中的性别相关因素
Metabolites. 2023 Oct 17;13(10):1087. doi: 10.3390/metabo13101087.
10
Computational screen for sex-specific drug effects in a cardiac fibroblast signaling network model.计算筛选心脏成纤维细胞信号网络模型中的性别特异性药物作用。
Sci Rep. 2023 Oct 10;13(1):17068. doi: 10.1038/s41598-023-44440-9.
本文引用的文献
1
Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).WISE研究（女性缺血综合征评估）中的十年死亡率
Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12). doi: 10.1161/CIRCOUTCOMES.116.003863.
2
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).炎症生物标志物作为无阻塞性冠状动脉疾病女性心力衰竭的预测指标：美国国立心肺血液研究所资助的女性缺血综合征评估（WISE）报告
PLoS One. 2017 May 19;12(5):e0177684. doi: 10.1371/journal.pone.0177684. eCollection 2017.
3
Epidemiology of heart failure with preserved ejection fraction.射血分数保留型心力衰竭的流行病学。
Nat Rev Cardiol. 2017 Oct;14(10):591-602. doi: 10.1038/nrcardio.2017.65. Epub 2017 May 11.
4
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告
Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.
5
Gender differences in the effects of cardiovascular drugs.心血管药物作用的性别差异。
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182. doi: 10.1093/ehjcvp/pvw042.
6
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).使用生物信息学评估模式（BIAS）改善心肌灌注数据的诊断和预后：美国国立心肺血液研究所赞助的女性缺血综合征评估（WISE）结果
Cardiovasc Diagn Ther. 2016 Oct;6(5):424-431. doi: 10.21037/cdt.2016.03.11.
7
Multiple Unfavorable Echocardiographic Findings in Takotsubo Cardiomyopathy Are Associated with Increased In-Hospital Events and Mortality.应激性心肌病的多项不良超声心动图表现与住院期间事件增加及死亡率相关。
J Am Soc Echocardiogr. 2016 Dec;29(12):1179-1187. doi: 10.1016/j.echo.2016.08.021. Epub 2016 Oct 11.
8
Cardiovascular Disease in Women: Clinical Perspectives.女性心血管疾病：临床视角
Circ Res. 2016 Apr 15;118(8):1273-93. doi: 10.1161/CIRCRESAHA.116.307547.
9
Peripartum Cardiomyopathy.围生期心肌病。
Circulation. 2016 Apr 5;133(14):1397-409. doi: 10.1161/CIRCULATIONAHA.115.020491.
10
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial.螺内酯对醛固酮拮抗剂试验治疗射血分数保留的心力衰竭患者健康相关生活质量纵向变化的影响
Circ Heart Fail. 2016 Mar;9(3):e001937. doi: 10.1161/CIRCHEARTFAILURE.114.001937.
Zotero 插件